In this study, we investigated amino acids Ala, Gly, glutamate (Glu), and glutamine (Gln) as potential biomarkers for glioma-defining molecular features (i.e., IDH mutation status), CNS WHO grade and patient overall survival. This evidence concerns the gene IDH1 and central nervous system cancer.